Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Ceapro Inc
V.CZO
Chemicals
Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human...
, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:CZO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
(9)
•••
jenksh
X
View Profile
View Bullboard History
Post by
jenksh
on Jan 07, 2024 11:48am
PGX YBG immune
Does Ceapro have a firm customer? Are they expecting immediate revenue from the new plant? Or do then have a plan to build first, then try and find customers.
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jan 07, 2024 11:44am
RE:Market share
So the question: What could the net present value be if 15% market share was targeted, the discount rate fell to 20% from 25%, and CZO had AEZS's C$113 million tax loss carryforwards? With the
...more
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource
posted Sep 19, 2024 9:00am by
Northstar Gold Corp.
-
|
The MOU grants Hunan Nonferrous the opportunity to explore and develop a near-surface NI43-101 gold mineral resource at Northstar’s 100%-owned Miller Copper-Gold Property, located 18 kilometers southeast of Kirkland Lake, Ontario. This will be achieved by diamond drilling up to 10,000 meters, allowing Hunan Nonferrous to earn a negotiated interest in the resultant NI43-101 gold resource. ...read more
(34)
•••
Tencents
X
View Profile
View Bullboard History
Comment by
Tencents
on Jan 07, 2024 11:30am
RE:RE:Diagnostic test
Yes apparently it is not a major market and big pharma is not interested by dfinition a patient is a one off test probably this market will not deliver much to aezs
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jan 07, 2024 11:29am
Market share
It keeps popping into my mind but I'm uncertain if it is true. Was the $40 million PGX-YBG immune booster plant that could produce 40 million doses per year with a $100 million net present value
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jan 07, 2024 11:01am
RE:RE:Diagnostic test
Significant pricing flexibility was expected for children given the Orphan Drug Designation for the test. Also, children are a realitively small group compared to adults allowing efficiencies. The
...more
(2245)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jan 07, 2024 10:32am
RE:Diagnostic test
Children market no larger than adult market....
(34)
•••
Tencents
X
View Profile
View Bullboard History
Comment by
Tencents
on Jan 07, 2024 9:21am
RE:RE:RE:RE:Diagnostic test
Yes that starts to establish a ball park the Sales indicated seem un achievable so unlikely to have anything like that in a deal The upfronts for clinical costs would be on the table of course
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jan 07, 2024 8:43am
RE:RE:RE:Diagnostic test
"Hard to evaluation but on like like basis it could be 1. upfront circa 30 m 2. targets - sales targets on that deal were not reached si the 179 probably was 0 3.royalties say 15 % - sales 3
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jan 07, 2024 8:23am
RE:RE:RE:Diagnostic test
Novo wanted AEZS's diagnostic test to synergize with its human growth hormone deficiency drug. 90% of its human growth hormone deficiency drug sales are to children however and AEZS's
...more
(34)
•••
Tencents
X
View Profile
View Bullboard History
Comment by
Tencents
on Jan 07, 2024 6:19am
RE:RE:Diagnostic test
Hard to evaluation but on like like basis it could be 1. upfront circa 30 m 2. targets - sales targets on that deal were not reached si the 179 probably was 0 3.royalties say 15 % - sales 3 annually -
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jan 06, 2024 11:19pm
RE:RE:Diagnostic test
US$24 million upfront... US$179 million in milestone payments linked to pediatric approval and revenue... 70% of pediatric trial costs covered... 15-18% royalties... Upon approval by the U.S. Food
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jan 06, 2024 11:17pm
RE:RE:Diagnostic test
Aeterna Zentaris Enters into Licensing and Assignment Agreement with Strongbridge for Macrilen™ (macimorelin) in the U.S. and Canada January 17, 2018 07:00 ET | Source: Aeterna
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jan 06, 2024 8:40pm
RE:Diagnostic test
Add it all up... This deal was six years ago... If CZO was to sell the diagnostic test for upfront cash upon approval for the pediatric market(the most important market) what could it get? US$24
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jan 06, 2024 8:18pm
Diagnostic test
It's six years after this deal. The pediatric trial costs have been absorbed as well as the time. Novo Nordisk bought them out and paid ~C$250 million(cash, equity) plus tiered royalties. Gilles
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jan 06, 2024 7:06pm
NASDAQ with Raymond James analyst coverage?
"Aeterna has engaged Raymond James Ltd. as its financial advisor..." Raymond James(Wikepedia): Revenue US$11.0 billion (2022) Operating
...more
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
EnviroGold Global Announces Appointment of Chief Operating Officer
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed